Want to see TSE:RAMM full AI Analyst Report?
Ramm Pharma (RAMM) Income Statement
Ramm Pharma Income Statement
Last quarter (Q3 2026), Ramm Pharma's total revenue was $260.01K, a decrease of 70.56% from the same quarter last year. In Q3, Ramm Pharma's net income was $-887.32K. See Ramm Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jan 26 | Jan 25 | Jan 24 | Jan 23 | Jan 22 |
|---|---|---|---|---|---|
| $ 3.36M | $ 4.34M | $ 5.07M | $ 3.90M | $ 4.12M | |
| $ 373.93K | $ 1.76M | $ 381.82K | $ 530.50K | $ -7.64K | |
| $ 4.89M | $ 8.52M | $ 7.47M | $ 8.46M | $ 6.63M | |
| Depreciation and Amortization | $ 734.76K | $ 1.21M | $ 1.34M | $ 1.02M | $ 732.63K |
| $ -3.78M | $ -15.23M | $ -6.30M | $ -19.91M | $ -6.36M | |
| $ -4.52M | $ -6.76M | $ -7.09M | $ -7.93M | $ -7.19M | |
| $ -4.38M | $ -9.73M | $ -625.08K | $ -13.02M | $ 92.01K | |
| $ -8.89M | $ -16.49M | $ -7.71M | $ -20.95M | $ -7.10M | |
| $ -8.91M | $ -16.50M | $ -7.72M | $ -20.96M | $ -7.11M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.07 | $ -0.14 | $ -0.06 | $ -0.17 | $ -0.07 |
| Diluted EPS | $ -0.07 | $ -0.14 | $ -0.06 | $ -0.17 | $ -0.07 |
| Weighted Average Shares Outstanding | 119.39M | 119.39M | 121.04M | 122.77M | 108.46M |
| Weighted Average Shares Outstanding (Diluted) | 119.39M | 119.39M | 121.04M | 122.77M | 108.46M |
Currency in CAD